Brez internetne povezave — prikazana je shranjena različica strani.

Adicet Bio Inc

USUSD
← Na Filter Delnic

Adicet Bio Inc (LSE:0HX7) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 2. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O Podjetju

Spletna Stran
adicetbio.com
Odnosi z Vlagatelji
adicetbio.com/investors/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
BOSTON, United States
Izvršni Direktor
Chen Schor
Zaposleni
102
Na Borzi od
08.01.2021 (LSE:0HX7)
Delnice v Obtoku
9.36 mio. na dan 2026-08-03
Prosto Prenosljive Delnice
7.43 mio.
Tržna Kapitalizacija
52.52 mio. USD
Notranje Osebe
1.08%
Institucionalni Vlagatelji
64.72%
Panoga (SIC)
Pharmaceutical Preparations
P/E
izguba
FCF
−85.0 mio. USD
Dolg
?
Dobiček in FCF — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
NAV
12.83 USD · P/NAV 0.51
Datum Bilance Stanja30.06.2026
Sredstva148 mio. USD
− Obveznosti28.0 mio. USD
= NAV (lastniški delež delničarjev podjetja)120 mio. USD
= Opredmetena NAV120 mio. USD
Delnice9 361 371
NAV na Delnico12.83 USD
Otipljiv NAV na Delnico12.83 USD
Cena Delnice (0HX7)6.5100 USD
P/NAV0.51
Zgodovina NAV
Datum Bilance StanjaNAVNAV na Delnico
30.06.2026120 mio. USD12.83 USD
31.03.2026140 mio. USD14.59 USD
31.12.2025159 mio. USD16.61 USD
30.09.2025109 mio. USD1.31 USD
30.06.2025133 mio. USD1.60 USD
31.03.2025161 mio. USD1.95 USD
31.12.2024187 mio. USD36.16 USD
30.09.2024212 mio. USD2.57 USD
Opis

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
US USA StocksACET glavnaUSD5.14 +5.11%navadne delnice
LSE London Stock Exchange0HX7 IOBUSD6.51 +0.00%navadne delnice

Cena v 3 Mesecih

dan rasti dan padcaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
RA Capital Management, L…9.96%932 6242026-06-30
Orbimed Advisors LLC.9.02%844 7872026-06-30
Franklin Resources, Inc.6.69%626 5712026-06-30
Citadel Advisors Llc4.62%432 7382026-06-30
Vanguard Capital Managem…3.67%343 2282026-06-30
Adage Capital Partners G…2.93%274 3752026-06-30
Renaissance Technologies…2.84%265 9452026-06-30
Stonepine Capital Manage…2.62%245 5182026-06-30
VANGUARD INDEX FUNDS-Van…2.57%240 9462026-06-30
Franklin Strategic Serie…2.41%225 1862026-07-31
Alyeska Investment Group…2.18%203 7992026-06-30
Schonfeld Strategic Advi…2.09%195 5142026-06-30
KLICKSTEIN LLOYD (Direct…≈1.16%108 5662025-06-11
VANGUARD INDEX FUNDS-Van…1.06%98 9122026-06-30
Bridgeway Funds, Inc.-Ul…0.92%85 9592026-06-30
Fidelity Concord Street…0.45%42 1112026-07-31
iShares Trust-iShares Mi…0.25%23 7812026-08-31
DUBIN STEVE (Director)≈0.24%22 7002025-06-11
Fidelity Concord Street…0.19%17 3492026-07-31
CHODAKEWITZ JEFFREY A. M…≈0.19%17 7002025-06-11
SINCLAIR ANDREW (Directo…≈0.19%17 7002025-06-11
Dimensional ETF Trust-Di…0.16%14 5202026-07-31
DFA INVESTMENT DIMENSION…0.15%14 2642026-07-31
Fidelity Concord Street…0.13%12 3612026-07-31
PENG KATIE (Director)≈0.13%11 8002025-06-11
ORBIMED ADVISORS, L.L.C.…——2026-04-08